SCHEMBL29939945

SCHEMBL29939945

Brc1cc(NCc2cnc3ccc(C4CC4)cc3c2)ccn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.39
▸ CYP1A2 P05177 1/20 0.36
▸ SLC6A2 P23975 1/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.36
▸ KDM1A O60341 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ MAOB P27338 1/20 0.34
▸ PSMB5 P28074 1/20 0.34
▸ DYRK1A Q13627 1/20 0.33
▸ CLK4 Q9HAZ1 1/20 0.33
▸ HDAC6 Q9UBN7 2/20 0.33
▸ CSF1R P07333 2/20 0.33
▸ IDO1 P14902 1/20 0.32
▸ KDM4C Q9H3R0 1/20 0.32
▸ IGF1R P08069 1/20 0.31
▸ KLKB1 P03952 1/20 0.31
▸ MAP4K1 Q92918 1/20 0.31
▸ USP30 Q70CQ3 1/20 0.31
▸ PDGFRB P09619 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29277919 1.00 NPC1 (0.39) NPC1CYP1A2SLC6A2SLC6A4SLC6A3
SCHEMBL29277993 0.91 NPC1 (0.41) NPC1CYP1A2SLC6A2SLC6A4SLC6A3
SCHEMBL29939902 0.91 NPC1 (0.41) NPC1CYP1A2SLC6A2SLC6A4SLC6A3
SCHEMBL29940532 0.72 PSMB5 (0.43) KDM1AMAOAMAOBPSMB5IDO1
SCHEMBL29940097 0.72 PSMB5 (0.43) KDM1AMAOAMAOBPSMB5IDO1
SCHEMBL29277971 0.72 PSMB5 (0.43) KDM1AMAOAMAOBPSMB5IDO1
SCHEMBL29302555 0.72 PSMB5 (0.43) KDM1AMAOAMAOBPSMB5IDO1
SCHEMBL29277953 0.72 PSMB5 (0.43) KDM1AMAOAMAOBPSMB5IDO1
SCHEMBL30960508 0.72 CYP2A6 (0.34) SLC6A2SLC6A4SLC6A3IGF1R
Hydrochloric Acid SCHEMBL29940427 0.71 PSMB5 (0.42) KDM1AMAOAMAOBPSMB5IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308229-A1 INHIBITORS OF PLASMA KALLIKREIN Takeda Pharmaceutical Company Limited (JP) 2024-01-24 — — EP disclosed
CN-117396469-A Inhibitors of plasma kallikrein 武田药品工业株式会社 2024-01-12 — — CN disclosed
WO-2022197763-A1 INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 — — WO disclosed
Send feedback